AI Verdict
RLX has stronger fundamentals based on our AI analysis.
RLX vs RLMD Fundamental Comparison
| Metric | RLX | RLMD |
|---|---|---|
| Revenue | N/A | $5.2M |
| Net Income | N/A | $-57.4M |
| Net Margin | N/A | -1,113.9% |
| ROE | N/A | -66.3% |
| ROA | N/A | -61.0% |
| Current Ratio | N/A | 14.62x |
| Debt/Equity | N/A | 0.00x |
| EPS | N/A | $-1.45 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLX vs RLMD: Frequently Asked Questions
Is RLX or RLMD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RLX has stronger fundamentals. RLX is rated SELL (15% confidence) while RLMD is rated STRONG SELL (78% confidence). This is not investment advice.
How does RLX compare to RLMD fundamentally?
RLX Technology Inc. has ROE of N/A vs RELMADA THERAPEUTICS, INC.'s -66.3%. Net margins are N/A vs -1,113.9% respectively.
Which stock pays higher dividends, RLX or RLMD?
RLX has a dividend yield of N/A or no dividend while RLMD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLX or RLMD for long term?
For long-term investing, consider that RLX has SELL rating with 15% confidence, while RLMD has STRONG SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLX vs RLMD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLX vs RLMD, the AI consensus favors RLX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.